These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9010860)

  • 1. New chemotherapy treatment options and implications for nursing care.
    Berg DT
    Oncol Nurs Forum; 1997; 24(1 Suppl):5-12. PubMed ID: 9010860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
    ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
    Saltz L; Janik JE
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-26-S5-30. PubMed ID: 9122740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topotecan in the treatment of gynecologic cancer.
    Coleman RL; Miller DS
    Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-55-S20-63. PubMed ID: 9425962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nursing considerations for managing topotecan-related hematologic side effects.
    Anastasia PJ
    Clin J Oncol Nurs; 2001; 5(1):9-13. PubMed ID: 11899407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic breast cancer: understanding current management options.
    McGinn K; Moore J
    Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy dose and dose intensity: analyzing data to guide therapeutic decisions.
    Gillespie TW
    Oncol Nurs Forum; 2001 Mar; 28(2 Suppl):5-10. PubMed ID: 11291209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caring for patients who experience chemotherapy-induced side effects: the meaning for oncology nurses.
    Fall-Dickson JM; Rose L
    Oncol Nurs Forum; 1999 Jun; 26(5):901-7. PubMed ID: 10382189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded treatment options in the adjuvant therapy of colon cancer: implications for oncology nurses.
    Viale PH
    Oncol Nurs Forum; 2006 Jan; 33(1):81-90. PubMed ID: 16470236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing care strategies for the management of side effects in patients treated for colorectal cancer.
    Taplin SC; Blanke CD; Baughman C
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-64-S18-70. PubMed ID: 9420023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
    Viale PH
    Semin Oncol Nurs; 2006 Aug; 22(3):144-51. PubMed ID: 16893743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifostine: drug profile and nursing implications of the first pancytoprotectant.
    Viele CS; Holmes BC
    Oncol Nurs Forum; 1998 Apr; 25(3):515-23. PubMed ID: 9568606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids and cancer survivors: issues in side-effect management.
    Palos GR
    Oncol Nurs Forum; 2008 Nov; 35 Suppl():13-9. PubMed ID: 18980935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of assessment rating scales for chemotherapy-induced oral mucositis.
    Jaroneski LA
    Oncol Nurs Forum; 2006 Nov; 33(6):1085-90; quiz 1091-3. PubMed ID: 17149392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing implications of mylotarg: a novel antibody-targeted chemotherapy for CD33+ acute myeloid leukemia in first relapse.
    Shannon-Dorcy K
    Oncol Nurs Forum; 2002 May; 29(4):E52-9. PubMed ID: 12011919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic therapy in patients receiving cancer chemotherapy.
    Marek C
    Oncol Nurs Forum; 2003; 30(2):259-71. PubMed ID: 12692660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of oral medications in patients with advanced breast cancer.
    Palmieri FM; Barton DL
    Semin Oncol Nurs; 2007 Nov; 23(4 Suppl 2):S17-22. PubMed ID: 18054678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
    Kearney N; Friese C
    Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.